• No results found

antagonists and inhibitors

ACE inhibitors – angiotensin II receptor antagonists: A useful combination therapy for ischemic heart disease

ACE inhibitors – angiotensin II receptor antagonists: A useful combination therapy for ischemic heart disease

... ACE inhibitors have demonstrated the Ang II receptor antagonists exert beneficial hemody- namic and neurohormonal effects in heart ...II antagonists have regularly been found to lower urinary albumin ...

9

Effects of proton pump inhibitors and histamine 2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile associated diarrhoea

Effects of proton pump inhibitors and histamine 2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile associated diarrhoea

... pump inhibitors (PPIs) is associated with an increased risk of acquiring Clostridium difficile -associated diarrhoea ...receptor antagonists (H2RAs) concurrently with CDAD-targeted antibiotic treatment ...

8

P2X-Selective Purinergic Antagonists Are Strong Inhibitors of HIV-1 Fusion during both Cell-to-Cell and Cell-Free Infection

P2X-Selective Purinergic Antagonists Are Strong Inhibitors of HIV-1 Fusion during both Cell-to-Cell and Cell-Free Infection

... purinergic inhibitors of HIV-1 fusion following cell-to-cell infection identifies P2X antagonists to be potent HIV-1 entry ...agonists, antagonists, and marketed drugs (Enzo BML-2820, ...

12

Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication

Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication

... protease inhibitors attainable in vivo to inhibit virus production in humans ...latency antagonists and anti- retroviral drugs simultaneously, but to deliver them to the same tissue and cellular ...

15

HISTORICAL OVERVIEW, DEVELOPMENT AND NEW APPROACHES IN DESIGN OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR ANTAGONISTS PART II

HISTORICAL OVERVIEW, DEVELOPMENT AND NEW APPROACHES IN DESIGN OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR ANTAGONISTS PART II

... (ACE) inhibitors and angiotensin receptor (ATR) antagonists, review includes their SAR analysis and chemical modification for improving their ...renin inhibitors, dual action receptor ...

12

Design and elaboration of a tractable tricyclic scaffold to synthesize druglike inhibitors of dipeptidyl peptidase 4 (DPP 4), antagonists of the C–C Chemokine Receptor Type 5 (CCR5), and highly potent and selective phosphoinositol 3 Kinase δ (PI3Kδ) inhib

Design and elaboration of a tractable tricyclic scaffold to synthesize druglike inhibitors of dipeptidyl peptidase 4 (DPP 4), antagonists of the C–C Chemokine Receptor Type 5 (CCR5), and highly potent and selective phosphoinositol 3 Kinase δ (PI3Kδ) inhibitors

... kinase family can be divided into three di ff erent classes depending on their domain structure. The main focus in current research is on the class 1 PI3Ks, which consist of four members. The majority of research is ...

21

Metformin With Either Histamine H2-Receptor Antagonists or Proton Pump Inhibitors: A Polypharmacy Recipe for Neuropathy via Vitamin B12 Depletion

Metformin With Either Histamine H2-Receptor Antagonists or Proton Pump Inhibitors: A Polypharmacy Recipe for Neuropathy via Vitamin B12 Depletion

... Figure 1 shows a schematic flowchart of the sequelae resulting from type 2 diabetes and GERD managed with metformin and acid-suppressing medications.. Discussion.[r] ...

6

Development of a novel cell based screening platform to identify inhibitors of viral interferon antagonists from clinically important viruses

Development of a novel cell based screening platform to identify inhibitors of viral interferon antagonists from clinically important viruses

... All viruses encode for at least one viral interferon (IFN) antagonist, which is used to subvert the cellular IFN response, a powerful antiviral innate immune response. Numerous in vitro and in vivo studies have ...

253

ASSOCIATION OF ANGIOTENSIN I CONVERTING ENZYME INHIBITORS WITH THE ANGIOTENSIN II RECEPTORS ANTAGONISTS

ASSOCIATION OF ANGIOTENSIN I CONVERTING ENZYME INHIBITORS WITH THE ANGIOTENSIN II RECEPTORS ANTAGONISTS

... enzyme inhibitors are well known mainly in the hypertension and heart failure treatment ...ACE inhibitors and with ARB (angiotensin II receptor blocker) also called angiotensin II receptor ...

5

TP53 mutant cell lines selected for resistance to MDM2 inhibitors retain growth inhibition by MAPK pathway inhibitors but a reduced apoptotic response

TP53 mutant cell lines selected for resistance to MDM2 inhibitors retain growth inhibition by MAPK pathway inhibitors but a reduced apoptotic response

... Tumour protein p53, encoded by the tumour suppres- sor gene TP53, is a transcription factor activating target genes that mediate various functions, including deoxy- ribonucleic acid (DNA) repair, metabolism, cell cycle ...

15

Comparison of prophylactic effect of UGIB and effects on platelet function between PPIs and H2RAs combined with DAPT: systematic review and meta-analysis

Comparison of prophylactic effect of UGIB and effects on platelet function between PPIs and H<sub>2</sub>RAs combined with DAPT: systematic review and meta-analysis

... pump inhibitors, PPIs, esomeprazole, pantoprazole, omeprazole, rabeprazole, lansoprazole, histamine receptor blocker, H 2 receptor antagonists, H 2 blocker, H 2 RA, cimeti- dine, ranitidine, famotidine, ...

11

A PROSPECTIVE OBSERVATIONAL STUDY ON COMPARISION OF EFFICACY OF PANTOPRAZOLE AND RANITIDINE FOR GASTROINTESTINAL ULCER PROPHYLAXIS IN CASE OF POLYPHARMCY IN A TERTIARY CARE HOSPITAL, BANGALORE

A PROSPECTIVE OBSERVATIONAL STUDY ON COMPARISION OF EFFICACY OF PANTOPRAZOLE AND RANITIDINE FOR GASTROINTESTINAL ULCER PROPHYLAXIS IN CASE OF POLYPHARMCY IN A TERTIARY CARE HOSPITAL, BANGALORE

... pump inhibitors with histamine-2 receptor antagonists in prevention of stress-related upper gastrointestinal bleeding in intensive care unit ...pump inhibitors vs. histamine-2 receptor ...

26

Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab

Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab

... factor inhibitors/ustekinumab resistant ...IL-17 antagonists have changed the benchmark for clinical efficacy, and it is likely that ixekizumab along with the other IL-17 antagonists are set to ...

9

Estrogen Receptor Antagonists Are Anti Cryptococcal Agents That Directly Bind EF Hand Proteins and Synergize with Fluconazole In Vivo

Estrogen Receptor Antagonists Are Anti Cryptococcal Agents That Directly Bind EF Hand Proteins and Synergize with Fluconazole In Vivo

... In addition to our previous work (13), two S. cerevisiae-based genome-wide chemical genetic studies have investigated the pos- sible mechanisms for the antifungal activity of tamoxifen (14, 31). Parsons et al. found that ...

11

An animal study to compare the degree of the suppressive effects on the afferent pathways of micturition between tamsulosin and sildenafil

An animal study to compare the degree of the suppressive effects on the afferent pathways of micturition between tamsulosin and sildenafil

... receptor antagonists and PDE-5 inhibitors may have an effect in improving the voiding functions through an inhibition of the neuronal activity in the afferent pathways of mictur- ition, such as the dorsal ...

8

Cholesterol ester hydrolase inhibitors reduce the production of synaptotoxic amyloid-beta oligomers

Cholesterol ester hydrolase inhibitors reduce the production of synaptotoxic amyloid-beta oligomers

... and PLAP caused the loss of synaptophysin and CSP from neuronal cultures. The presence CM from 7PA2 cells treated with squalestatin, PAF antagonists or CEH inhibitors protected neurons against the brain ...

29

Potentially inappropriate medication use in nursing homes: an observational study using the NORGEP-NH criteria

Potentially inappropriate medication use in nursing homes: an observational study using the NORGEP-NH criteria

... ACE-inhibitors: angiotensin-converting enzyme inhibitors; ADR: adverse drug reaction; ARB: angiotensin receptor blockers; AT2-antagonists: angiotensin II receptor antagonists; BPSD: Beha[r] ...

11

 NEW INSIGHTS INTO MOLECULAR TARGETS FOR DEPRESSION

 NEW INSIGHTS INTO MOLECULAR TARGETS FOR DEPRESSION

... (SSRI/5-HT1A antagonists, SSRI/5-HT2C antagonists, SSRI/alpha-2 adrenergic antagonists, triple reuptake inhibitors, dopamine agonists, targeting GABA) and beyond monoaminergic strategies ...

7

The role of reversible ubiquitylation in EGF signalling

The role of reversible ubiquitylation in EGF signalling

... Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of [r] ...

213

Short- and long-term physiologic and pharmacologic control of blood pressure in pediatric patients

Short- and long-term physiologic and pharmacologic control of blood pressure in pediatric patients

... the antagonists of angiotensin II type 1 receptor blockers (ARBs), eg, losartan, in ...renin inhibitors, eg, aliskiren. Finally, selective aldosterone antagonists, eg, eplerenone, are now available ...

10

Show all 10000 documents...

Related subjects